Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.70 |
| ▸ | ZDHHC2 | Q9UIJ5 | 3/20 | 0.70 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.64 |
| ▸ | EGFR | P00533 | 1/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | HTR7 | P34969 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1700688 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL1700805 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL6131120 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL1700944 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL2536775 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL1700721 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL2530353 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL5362502 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL444526 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 | |
| SCHEMBL2533024 | 1.00 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1EGFRCASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983462-B1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2025-01-08 | — | — | EP | disclosed |
| US-20220306791-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2022-09-29 | — | — | US | disclosed |
| US-11427728-B2 | Method for producing aqueous dispersions | BASF SE (DE) | 2022-08-30 | — | — | US | disclosed |
| EP-3983462-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-11292861-B2 | Aqueous polymer dispersion | BASF SE (DE) | 2022-04-05 | — | — | US | disclosed |
| US-20210292457-A1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2021-09-23 | — | — | US | disclosed |
| WO-2020249706-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2020-12-17 | — | — | WO | disclosed |
| EP-3491029-B1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2020-05-20 | — | — | EP | disclosed |
| US-20190218414-A1 | METHOD FOR PRODUCING AQUEOUS DISPERSIONS | BASF SE (DE) | 2019-07-18 | — | — | US | disclosed |
| EP-3263209-A1 | MEMBRANES COMPRISING POLYMERIC PARTICLE LAYERS | BASF SE (DE) | 2018-01-03 | — | — | EP | disclosed |
| US-9382442-B2 | Aqueous binder compositions | BASF SE (DE) | 2016-07-05 | — | — | US | disclosed |
| EP-2855579-B1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-20150099843-A1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2015-04-09 | — | — | US | disclosed |
| US-8329800-B2 | Binder compositions comprising boric acid or boric acid salt | BASF SE (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20110312240-A1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110257302-A1 | BINDER COMPOSITIONS COMPRISING BORIC ACID OR BORIC ACID SALT | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306791-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | LPO, SORD, GYS1 | ZDHHC20 3165/4885ZDHHC2 3529/4885EPHX1 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.